Strikingly, using RISH we observed downregulation of TGFBR2 in the majority of clinical tumor samples when compared with adjacent histological normal epithelial cells and infiltrating lymphocytes (Fig. 5B). This evidence concerns the gene TGFBR2 and neoplasm.